1. Home
  2. VALN vs HIPO Comparison

VALN vs HIPO Comparison

Compare VALN & HIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • HIPO
  • Stock Information
  • Founded
  • VALN 2012
  • HIPO 2015
  • Country
  • VALN France
  • HIPO United States
  • Employees
  • VALN N/A
  • HIPO N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • HIPO Property-Casualty Insurers
  • Sector
  • VALN Health Care
  • HIPO Finance
  • Exchange
  • VALN Nasdaq
  • HIPO Nasdaq
  • Market Cap
  • VALN 989.8M
  • HIPO 842.4M
  • IPO Year
  • VALN 2021
  • HIPO N/A
  • Fundamental
  • Price
  • VALN $8.63
  • HIPO $32.55
  • Analyst Decision
  • VALN Strong Buy
  • HIPO Strong Buy
  • Analyst Count
  • VALN 4
  • HIPO 5
  • Target Price
  • VALN $16.00
  • HIPO $34.40
  • AVG Volume (30 Days)
  • VALN 153.6K
  • HIPO 185.6K
  • Earning Date
  • VALN 08-12-2025
  • HIPO 08-06-2025
  • Dividend Yield
  • VALN N/A
  • HIPO N/A
  • EPS Growth
  • VALN N/A
  • HIPO N/A
  • EPS
  • VALN N/A
  • HIPO N/A
  • Revenue
  • VALN $230,566,060.00
  • HIPO $425,000,000.00
  • Revenue This Year
  • VALN $15.55
  • HIPO $27.97
  • Revenue Next Year
  • VALN $23.93
  • HIPO $25.47
  • P/E Ratio
  • VALN N/A
  • HIPO N/A
  • Revenue Growth
  • VALN 25.47
  • HIPO 43.15
  • 52 Week Low
  • VALN $3.62
  • HIPO $15.74
  • 52 Week High
  • VALN $12.25
  • HIPO $35.44
  • Technical
  • Relative Strength Index (RSI)
  • VALN 46.03
  • HIPO 59.20
  • Support Level
  • VALN $8.71
  • HIPO $30.65
  • Resistance Level
  • VALN $9.05
  • HIPO $33.93
  • Average True Range (ATR)
  • VALN 0.46
  • HIPO 1.10
  • MACD
  • VALN -0.38
  • HIPO 0.06
  • Stochastic Oscillator
  • VALN 13.63
  • HIPO 67.40

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About HIPO Hippo Holdings Inc.

Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.

Share on Social Networks: